The natural compound stachyose targets SGLT2-mediated metabolic reprogramming to ameliorate diabetic kidney disease
{{output}}
Background: Diabetic kidney disease (DKD) is a leading cause of end-stage renal disease with no curative treatment currently available. Aberrant metabolic reprogramming in renal tubular epithelial cells contributes to renal fibro... ...
